Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/12
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 05/23/18
End: 12/27/24
Due: 12/27/25
Phase: N/A
Priority: Normal
Start: 06/30/13
End: 03/31/15
Due: 03/31/16
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study in Intensive Care Patients to Investigate the Clinical Effect of Repetitive Orally Inhaled Doses of AP301 on Alveolar Liquid Clearance in Acute Lung Injury | NCT01627613 | Apeptico Forschung und Entwicklung GmbH | user2@example.com | None | 2012-07-31 | 2014-08-31 | 2015-08-31 | - | - | 2025-07-14 |
| Safety and Preliminary Efficacy of Sequential Multiple Ascending Doses of Solnatide to Treat Pulmonary Permeability Oedema in Patients With Moderate-to-severe ARDS | NCT03567577 | Apeptico Forschung und Entwicklung GmbH | user2@example.com | None | 2018-05-23 | 2024-12-27 | 2025-12-27 | - | - | 2025-07-14 |
| Study in Intensive Care Patients Regarding the Effect of Inhaled AP-301 After Primary Graft Dysfunction After Lung Transplantation | NCT02095626 | Apeptico Forschung und Entwicklung GmbH | user2@example.com | None | 2013-06-30 | 2015-03-31 | 2016-03-31 | - | - | 2025-07-14 |